Exclzyme® EN - References

I Product Info I Ingredients I Recommended Use I Clinical Trials I Research Brief I References 

exclzymelg

Indication: enzymatic deficiency, indigestion, dysbolism, degenerative changes in joints, increased blood viscosity, inflammations, traumas, wounds, postoperative recovery period.

Actions: improves digestion, regulates metabolism, has an anti-inflammatory and analgetic effect, has immunomodulatory, antiaggregatory, and fibrinolytic action, stimulates enzyme activity, speeds up the wound healing.

Ingredients (per 1 tablet):

Exclzyme®EN – 250 mg (30,000 EU): Peptizyme SP®EN, protease, papain, bromeline, amylase, lipase, rutin, amla (Emblica Officinalis).

 

Order this item

Low USA domestic & international shipping

Exclzyme® EN - References:

  1. Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health, September 2002. NIH Publication No. 02-5215.
  2. Gey KF. Vitamins E plus C and interacting conutrients required for optimal health. A critical and constructive review of epidemiology and supplementation data regarding cardiovascular disease and cancer. Biofactors 1998;7:113-74.
  3. Brown WV. Niacin for lipid disorders. Postgrad Med 1995;98:185–93 [review].
  4. Guyton JR. Effect of niacin on atherosclerotic cardiovascular disease. Am J Cardiol 1998;82(12A):18U–23U [review].
  5. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
  6. Bottiglieri T, Reynolds EH, Laundy M. Folate in CSF and age. J Neurol Neurosurg Psychiatry 2000; 69: 562
  7. Homocysteine Lowering Trialists‘ Collaboration: Lowering blood homocysteine with folic acid based supplements: metaanalysis of randomised trials. BMJ 1998;316:894-8.
  8. Institute of Medicine. Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. National Academy Press. Washington, DC, 1999.
  9. Clostre F. From the body to the cell membranes: the different levels of pharmacological action of Ginkgo biloba extract. In: Rokan (Ginkgo biloba): Recent Results in Pharmacology and Clinic.Fünfgeld EW, ed. Berlin: Springer-Verlag, 1988, 180-98.
  10. Jialal I and Fuller CJ. Effect of vitamin E, vitamin C and beta-carotene on LDL oxidation and atherosclerosis. Can J Cardiol 1995;11 Suppl G:97G-103G.
  11. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444-9
  12. Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994;139:1180-9.
  13. Wald DS, Bishop L, Wald NJ, Law M, Hennessy E, Weir D, McPartlin J, Scott J. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 2001;161:695-700.
  14. Pittler MH , Schmidt K, Ernst E. – Complementary Medicine, Peninsula Medical School, Universities of Exeter and Plymouth , 25 Victoria Park Road , Exeter EX2 4NT, United Kingdom. Am J Med. 2003 Jun 1 ; 114 (8): 665-74